Peptides TRIZ Cases

Synthetic ligands bind PCSK9 to induce conformational shifts that alter LDL receptor affinity and modulate circulating cholesterol levels.

Asymmetric synthesis of a chiral imine avoids racemic waste and expensive catalysts during Ramipril manufacturing.

Macrocyclic compounds bind PD-L1 to block immune evasion pathways.

Acylated tRNA introduces non-natural amino acids into peptides using ribosome catalysis, forming cyclic motifs without complex chemical processes.

Segmented targeting structures enable direct measurement of calcium ion migration through MAM, excluding interference from other mitochondrial channels.

Peptide-drug conjugates bind EGFR receptors to enhance cellular uptake, overcoming blood-brain barrier permeability and efflux pump resistance.

MMAF conjugates bypass P-glycoprotein efflux to overcome drug resistance while reducing patient toxicity.

A targeted imaging probe uses a hydrophilic linker to enhance solubility and binding affinity for EGFR expressing cells.

A sweetener blend combining purified thaumatin with mogrosides to enhance sweetness and improve temporal profiles.

Cell-specific peptide liposomes localize PARP-1 inhibitors in the infarct border zone, reducing systemic side effects while boosting therapeutic efficacy.

Ether solvents enable Lewis acid promoted rearrangement of boron ate complexes on multi-kilogram scale.

Covalently linking AAN and RGD sequences creates a tandem polypeptide that targets tumor cells, vessels, and macrophages, overcoming single-target limitations.

Reducing glucose dehydrogenase activity in producer cells redirects metabolic flux to increase rhamnolipid yields and carbon source versatility.

Intramolecular arylation with a directing group expands amino acid selection range, overcoming reaction site restrictions in cyclic peptide synthesis.

Enzymatic hydrolysis of black shark skin yields antioxidant polypeptides, replacing synthetic additives with carcinogenic risks.

Acylation of hindered amines assembles functionalized bis-peptides, enabling controlled placement of functional groups to overcome synthetic complexity.

A pentapeptide sequence targets tumor cells expressing integrin alpha v beta 3 with high affinity.

Neutral organic amine salts prevent intramolecular lactam formation in ACE inhibitor dicarboxylic acids, eliminating skin irritation from pH extremes.

Chromosomally integrated mKate2 transgenes resolve unpredictable development by enabling consistent purple fluorescence in fertile ornamental fish.

Cyclophilin D inhibitors target gatekeeper residues in the S2 pocket to modulate mitochondrial permeability transition pore activity.

Transgenic pigs with CFTR mutations mimic human disease physiology, resolving the trade-off between model accuracy and maintenance complexity.

Quantifying preimplantation factor binding to circulating immune cells detects endometriosis and recurrent pregnancy loss without invasive surgery.

A thermoreversible gel composition with oligopeptides supports cell proliferation and tissue preservation.

Activatable polypeptides control lipid vesicle permeability via pH or enzymatic triggers, reducing background signal interference in microbial detection assays.

A synthetic peptide complex targets cholecystokinin B receptors with high specificity.

Mutated pro regions in modified polynucleotides increase protease secretion efficiency and enzymatic activity levels in Bacillus species.

Engineered tRNAPyl introduces non-natural amino acids to restore truncated proteins without aminoglycoside toxicity.

Genetically engineered microorganisms convert inexpensive carbon sources into N-acetylneuraminic acid through optimized heterologous enzymatic pathways.

A dual-cleavage ester-glycoside linker uses a monosaccharide moiety to shield the antibody-drug conjugate from premature plasma hydrolysis.

Fluoroaryl-thiol-click chemistry staples peptides via nucleophilic aromatic substitution to enhance cellular uptake.

Click chemistry simplifies conjugate synthesis by removing orthogonal protecting steps while enhancing pharmacokinetic stability.

A system detects drug active sites by analyzing pathogenic mutations in three-dimensional protein structures.

Taurine and glutathione in the aqueous preservation solution reduce oxidative stress during oxygenated perfusion to maintain metabolic quality.

Self-stabilizing linkers prevent maleimide transfer to plasma thiols by catalyzing succinimide ring hydrolysis.

A fluorescent probe detects pancreatic cancer cells through specific enzymatic hydrolysis.

A polypeptide-based block copolymer forms micelles that collapse at specific pH levels to release therapeutic agents.

A transgenic mouse model uses Cre recombinase to delete the HuR gene in neurons upon tamoxifen induction.

Covalent peptide modulators bind HLA-E to block CD94/NKG2A signaling, restoring NK cell cytotoxicity against cancer cells.

A leptin receptor affinity peptide anchors to collagen scaffolds to recruit mesenchymal stem cells.

Aniline acts as a catalyst and radiostabilizer to increase reaction rate and yield of radiolabeled imine-oxy products at acidic pH.

Substituting threonine with lysine at position 813 in the LOV protein increases protein yield by 40% in submerged cultures.

Specific amino acid arrangements enable selective stimulation of disordered protein degradation while sparing ordered proteins.

X-ray diffraction determines ROCK I inhibitor complex structures to resolve active site information gaps.

Fc-III derived peptide mediates site-selective acetylation of Lys248 in human immunoglobulin G, resolving heterogeneous antibody-drug conjugate populations.

Peptoid-based chelating ligands bind actinides via tailored side chains, avoiding siderophore hydrolysis.

Segmented bioluminescent indicators produce unique spectral signatures to resolve temporal overlap in neural signals.

Specific antigenic proteins differentiate infected from vaccinated animals, resolving cross-reactivity issues.